Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cingulate Inc.

NASDAQ: CING · Life Sciences · 4 alerts · CIK 1862150

Share price
$3.75Close, Nov 16
Market cap
$56.1M
Shares outstanding
14.96MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cingulate Inc. filings on SEC EDGAR ↗

4:31 PM ET 8-K
Executive Compensation

Cingulate Executive Compensation

Cingulate Inc.'s subsidiary, Cingulate Therapeutics LLC, entered into an amendment to the employment agreement of Matthew N. Brams, the company's Executive Vice President and Chief Medical Officer. The amendment extends the trial period for Mr. Brams' full-time employment from September 30, 2026, to December 31, 2026.

Term
through Dec 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.